The Modulation of Fibrosis In Scleroderma by 3-Deoxyglucosone
Abstract
Scleroderma is a disease where excess collagen is deposited in the skin and internal organs. The tissues become hard and in the end fail to function. To date there is no cure, nor is there an effective therapy that will control the deposition of the collagen. The goals of this application were to investigate the cellular signaling within fibroblasts that were mediated by the glycation end product, 3DG. We find that 3DG decreases the expression of collagens and therefore we proposed to understand the cellular signaling in fibroblasts in response to this compound. 3DG-collagen induced ER stress leading to caspase 3 activation, and decreased cell proliferation. Furthermore, 3DG-collagen induced changes in integrins and growth factor expression. Furthermore, we found that p38 MAPK was a crucial protein that regulated whether the fibroblast responded to a stress signal or a growth signal. The data obtained from this grant has allowed us to identify two candidate chemicals that lower collagen expression by SSc fibroblasts.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2011
- Accession Number
- ADA561077
Entities
People
- Carol Artlett
Organizations
- Drexel University